Literature DB >> 1417755

Kinetic and inhibition studies on catechol-O-methyltransferase affinity labelling by N-(3,4-dihydroxyphenyl)maleimide.

F J Piedrafita1, E Fernandez-Alvarez, O Nieto, K F Tipton.   

Abstract

Initial velocity and product inhibition studies have been performed on soluble catechol-O-methyltransferase which has been partially purified from pig liver. The results are consistent with an ordered reaction mechanism, in which S-adenosyl-L-methionine (AdoMet) is the leading substrate. The enzyme is irreversibly inhibited by maleimide derivatives in a biphasic manner, which suggests a differential reaction with two thiol groups. N-(3,4-Dihydroxyphenyl)maleimide, which has a reactive moiety (maleimide ring) and an affinity moiety (catechol ring), acts as an affinity labelling compound on the more reactive SH group; AdoMet and Mg2+ protect against this modification. Total protection of this SH group results in a pseudo-first-order inhibition of the enzyme, with the apparent rate constant being proportional to the inhibitor concentration. All the other maleimide derivatives studied inhibited the enzyme by reacting with one of the two SH groups in a non-specific manner. The reaction of the other, more reactive, SH group was either specific (active-site-directed) or non-specific, depending on the substituent present in the affinity moiety and also on the length of an intermediate chain of methylene groups present between this moiety and the reactive maleimide ring. In the presence of both AdoMet and Mg2+, 3,5-dinitrocatechol, a reversible inhibitor of the enzyme which is competitive with respect to the catechol substrate, protects the enzyme from inactivation by any of the maleimide derivatives. The adducts of these maleimide derivatives formed with dithiothreitol inhibit the enzyme reversibly, showing inhibition patterns that are consistent with the mechanism deduced from the initial velocity and product inhibition studies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417755      PMCID: PMC1132995          DOI: 10.1042/bj2860951

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  A method for characterizing the type and numbers of groups involved in enzyme action.

Authors:  W J RAY; D E KOSHLAND
Journal:  J Biol Chem       Date:  1961-07       Impact factor: 5.157

2.  Enzymatic O-methylation of epinephrine and other catechols.

Authors:  J AXELROD; R TOMCHICK
Journal:  J Biol Chem       Date:  1958-09       Impact factor: 5.157

3.  A micro biuret method for protein determination; determination of total protein in cerebrospinal fluid.

Authors:  J GOA
Journal:  Scand J Clin Lab Invest       Date:  1953       Impact factor: 1.713

4.  Evidence for sulfhydryl groups at the active site of catechol-O-methyltransferase.

Authors:  R T Borchardt; D R Thakker
Journal:  Biochim Biophys Acta       Date:  1976-10-11

5.  Catechol O-methyltransferase. 1. Kinetics of tropolone inhibition.

Authors:  R T Borchardt
Journal:  J Med Chem       Date:  1973-04       Impact factor: 7.446

6.  Kinetics of purified catechol O-methyltransferase.

Authors:  L Flohe; K P Schwabe
Journal:  Biochim Biophys Acta       Date:  1970-12-16

7.  Catechol O-methyltransferase. 7. Affinity labeling with the oxidation products of 6-aminodopamine.

Authors:  R T Borchardt; E E Smissman; D Nerland; J R Reid
Journal:  J Med Chem       Date:  1976-01       Impact factor: 7.446

8.  Purification and kinetic mechanism of human brain soluble catechol-O-methyltransferase.

Authors:  D R Jeffery; J A Roth
Journal:  J Neurochem       Date:  1985-03       Impact factor: 5.372

9.  Kinetic studies on the O-methylation of dopamine by human brain membrane-bound catechol O-methyltransferase.

Authors:  A J Rivett; J A Roth
Journal:  Biochemistry       Date:  1982-04-13       Impact factor: 3.162

10.  Rapid and sensitive single-step radiochemical assay for catechol-O-methyltransferase.

Authors:  G Zürcher; M Da Prada
Journal:  J Neurochem       Date:  1982-01       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.